Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "testing"

740 News Found

Briefs: Indoco Remedies and Panacea Biotec
News | April 14, 2026

Briefs: Indoco Remedies and Panacea Biotec

Panacea Biotec receives LoA from CMSS


Roche wins CE mark for blood-based MS brain damage test
News | April 14, 2026

Roche wins CE mark for blood-based MS brain damage test

The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain


Unichem’s US arm recalls Buspirone tablets after stability test OOS result
News | April 13, 2026

Unichem’s US arm recalls Buspirone tablets after stability test OOS result

No adverse events reported; recall involves 5 mg 500-count bottles in the US market


Glycomine completes enrollment in Phase 2b trial for rare genetic disorder
Clinical Trials | April 10, 2026

Glycomine completes enrollment in Phase 2b trial for rare genetic disorder

The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation


Neuberg Diagnostics unveils Neubee to make preventive healthcare simpler
Healthcare | April 09, 2026

Neuberg Diagnostics unveils Neubee to make preventive healthcare simpler

New digital health companion uses friendly, jargon-free communication to help users better understand reports


Sharda Hospital performs Greater Noida’s first kidney transplant Under Ayushman Bharat
Hospitals | April 09, 2026

Sharda Hospital performs Greater Noida’s first kidney transplant Under Ayushman Bharat

Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care


Redcliffe Labs sells Crysta IVF to MMG Group’s Moon Care to sharpen diagnostics play
Healthcare | April 09, 2026

Redcliffe Labs sells Crysta IVF to MMG Group’s Moon Care to sharpen diagnostics play

Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership


MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases
Biopharma | April 07, 2026

MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases

India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases


AstraZeneca India, Telangana Govt partner for AI-led lung cancer screening in public hospitals
Digitisation | April 07, 2026

AstraZeneca India, Telangana Govt partner for AI-led lung cancer screening in public hospitals

MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations